Company: IONQ
Filing Date: 2025-10-17
Form Type: 424B7
Source: 0000950142-25-002826
Chunk: 13

Company: IonQ, Inc.
Filing Date: 2025-10-17
Form: 424B7
Chunk 13
---
 amend the registration statement
of which this prospectus supplement is a part, and file a prospectus supplement to describe the agreement between such selling stockholder
and the broker-dealer.

Under applicable rules and regulations under
the Exchange Act, any person engaged in the distribution of the resale shares may not simultaneously engage in market making activities
with respect to the shares, for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.
In addition, the selling stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder,
including Regulation M, which may limit the timing of purchases and sales of the shares by the selling stockholders or any other person.
We will make copies of this prospectus supplement and related prospectus available to the selling stockholders and have informed them
of the need to deliver a copy of this prospectus supplement and related prospectus to each purchaser at or prior to the time of the sale
(including by compliance with Rule 172 under the Securities Act).

The aggregate proceeds to the selling stockholders
from the sale of the shares offered by them will be the purchase price of the shares less discounts or commissions, if any. Each of the
selling stockholders reserves the right to accept and, together with its agents from time to time, to reject, in whole or in part, any
proposed purchase of the shares to be made directly or through agents. We will not receive any of the proceeds from this offering.

| S-11 |

<div align='center'>LEGAL MATTERS</div>

The validity of the shares of our common stock
offered by this prospectus supplement will be passed upon for us by Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York, New York.

| S-12 |

<div align='center'>EXPERTS</div>

The consolidated financial statements of IonQ,
Inc. appearing in IonQ, Inc.’s Annual Report (Form 10-K) for the year ended December 31, 2024, and the effectiveness of IonQ, Inc.’s
internal control over financial reporting as of December 31, 2024, have been audited by Ernst & Young LLP, independent registered
public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated
financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as experts
in accounting and auditing.

| S-13